Skip to main content

BD Completes $230M GeneOhm Acquisition

NEW YORK, Feb. 14 (GenomeWeb News) - Becton Dickinson today said it has completed its acquisition of GeneOhm Sciences for $230 million.

 

The acquisition was finalized in accordance with terms originally disclosed in an announcement on Jan 10.

 

BD said in a statement that the acquisition complements its microbiology play and "validates its commitment to expansion in molecular diagnostics."

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.